Steven Cohen’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.2M Buy
+1,990,545
New +$29.7M 0.02% 1042
2026
Q2
– Sell
-2,439,637
Closed -$43M – 3953
2026
Q1
$43M Buy
2,439,637
+397,781
+19% +$7.99M 0.06% 434
2025
Q4
$40.3M Sell
2,041,856
-783,326
-28% -$14.1M 0.05% 505
2025
Q3
$49.3M Buy
2,825,182
+840,204
+42% +$12.5M 0.08% 265
2025
Q2
$27.8M Buy
+1,984,978
New +$32M 0.05% 390
2025
Q1
– Sell
-1,785,480
Closed -$20.1M – 2002
2024
Q4
$20.1M Buy
+1,785,480
New +$20.9M 0.04% 449
2024
Q2
– Sell
-37,600
Closed -$186K – 1819
2024
Q1
$186K Buy
+37,600
New +$241K ﹤0.01% 1914
2023
Q3
– Sell
-688
Closed -$3.96K – 2422
2023
Q2
$3.96K Sell
688
-1,273
-65% -$8.23K ﹤0.01% 1966
2023
Q1
$12.5K Sell
1,961
-168,239
-99% -$1.6M ﹤0.01% 2015
2022
Q4
$2M Buy
+170,200
New +$2.07M 0.01% 933

Other funds holding ALHC

Steven Cohen's ALHC Position: Q3 2026 in Review

Steven Cohen opened a new position in Alignment Healthcare (ALHC) in Q3 2026: 1,990,545 shares worth $16.2M. The stake represents 0.02% of the portfolio and ranks #1042 among its holdings. This is a return to the name: Steven Cohen previously reported a position in ALHC as recently as Q1 2026.

Steven Cohen first reported a position in ALHC in Q4 2022 and has held it in 10 quarters since. The position peaked at $49.3M in Q3 2025. 322 funds tracked by Wall St. Rank hold ALHC as of Q3 2026.

  • Steven Cohen held 1,990,545 shares of Alignment Healthcare worth $16.2M as of Q3 2026.
  • Alignment Healthcare was a new Steven Cohen position in Q3 2026.
  • Alignment Healthcare made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #1042 holding.
  • Steven Cohen first reported a position in Alignment Healthcare in Q4 2022 and has held it in 10 quarters since.
  • Steven Cohen's Alignment Healthcare position peaked at $49.3M in Q3 2025.
  • 322 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.